Lung cancer remains the leading cause of cancer mortality in men and women in the US
and worldwide. About 90% of lung cancer cases are caused by smoking and the use of …

Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …

Malignant mesothelioma (MM) is an aggressive cancer primarily diagnosed on the basis of
histological criteria. The 2015 World Health Organization classification subdivides …

The most common malignancies that develop in carriers of BAP1 germline mutations include
diffuse malignant mesothelioma, uveal and cutaneous melanoma, renal cell carcinoma, and …

Inflammation can be induced by chronic infection, inflammatory diseases and
physicochemical factors. Chronic inflammation is estimated to contribute to approximately …

Malignant pleural mesothelioma (MPM) is an aggressive neoplasm associated with
asbestos exposure. Although previous studies based on candidate gene approaches have …

Purpose This multi-institutional registry study evaluated cytoreductive surgery (CRS)
combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for diffuse malignant …

Background Monoclonal antibodies to cytotoxic T-lymphocyte antigen 4 (CTLA4) have
therapeutic activity in different tumour types. We aimed to investigate the efficacy, safety, and …

OBJECTIVE: To carry out a descriptive analysis of mesothelioma deaths reported worldwide
between 1994 and 2008. METHODS: We extracted data on mesothelioma deaths reported …

Malignant mesothelioma (MM) is an aggressive tumor arising primarily from the pleural or
peritoneal cavities. It develops by asbestos exposure after a long latency, which is …